The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Why Is Loryna 28 Day So Hard to Find? [Explained for 2026]
Loryna 28 Day keeps going out of stock at pharmacies across the country. Here's exactly why it happens and what you can do about it.
Why Is Mecobalamin (Vitamin B12) So Hard to Find? [Explained for 2026]
Patients across the US are struggling to find mecobalamin (methylcobalamin) at their pharmacy. Here's why it happens and what you can do about it in 2026.
Why Is Methylergonovine So Hard to Find? [Explained for 2026]
Struggling to fill your Methylergonovine prescription? You're not alone. Here's why this postpartum medication is so difficult to find in 2026—and what you can do about it.
Why Is Nepafenac So Hard to Find? [Explained for 2026]
Struggling to find Nepafenac (Nevanac or Ilevro) at your pharmacy before cataract surgery? Here's why it's sometimes hard to fill and what you can do.
37,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Why Is Pancreaze So Hard to Find? [Explained for 2026]
Struggling to find Pancreaze at your pharmacy in 2026? Learn why this pancreatic enzyme medication can be difficult to locate and what you can do right now.
Why Is Retacrit So Hard to Find? [Explained for 2026]
Retacrit (epoetin alfa-epbx) has faced repeated supply disruptions. Here's why it can be hard to find and what you can do about it in 2026.
Why Is Sirolimus So Hard to Find? [Explained for 2026]
Sirolimus (Rapamune) can be surprisingly difficult to find at retail pharmacies. Here's why — and what transplant and LAM patients can do about it in 2026.
Why Is Spravato So Hard to Find? [Explained for 2026]
Spravato isn't in a traditional drug shortage — but it's still hard to access. Learn why finding a Spravato treatment center is so challenging in 2026.
Why Is Stelara So Hard to Find? [Explained for 2026]
Stelara (ustekinumab) can be difficult to access due to specialty pharmacy requirements, insurance hurdles, and the shifting biosimilar landscape. Here's what's happening in 2026.
Why is Yusimry so Hard to Find? [Explained for 2026]
Yusimry (adalimumab-aqvh) is FDA-approved and in supply — so why can't patients find it? Here's what's really driving Yusimry availability issues in 2026.
Why Is Zafemy So Hard to Find? [Explained for 2026]
Struggling to find Zafemy at your pharmacy? Here's why some patients have trouble locating the birth control patch — and what you can do about it.
Why Is Emend So Hard to Find? [Explained for 2026]
Emend (aprepitant) has faced supply disruptions, leaving cancer patients scrambling before chemotherapy. Here's why—and what you can do about it in 2026.